133 related articles for article (PubMed ID: 18637135)
1. Predicting possible zonisamide hypersensitivity syndrome.
Neuman MG; Shear NH; Malkiewicz IM; Kessas M; Lee AW; Cohen L
Exp Dermatol; 2008 Dec; 17(12):1045-51. PubMed ID: 18637135
[TBL] [Abstract][Full Text] [Related]
2. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
Neuman MG; Cohen L; Nanau RM; Hwang PA
Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides.
Neuman MG; Shear NH; Malkiewicz IM; Taeri M; Shapiro LE; Krivoy N; Haber J; Gomez M; Fish J; Cartotto R; Cohen L
Transl Res; 2007 May; 149(5):243-53. PubMed ID: 17466923
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
[TBL] [Abstract][Full Text] [Related]
5. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.
Neuman MG; Malkiewicz IM; Shear NH
Clin Biochem; 2000 Oct; 33(7):517-24. PubMed ID: 11124336
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing.
Tornero P; De Barrio M; Baeza ML; Herrero T
Contact Dermatitis; 2004 Aug; 51(2):57-62. PubMed ID: 15373844
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
[TBL] [Abstract][Full Text] [Related]
9. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
10. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
Wellmer J; Wellmer S; Bauer J
Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation.
Neuman MG; McKinney KK; Nanau RM; Kong V; Malkiewicz I; Mazulli T; Moussa G; Cohen LB
Transl Res; 2013 May; 161(5):430-40. PubMed ID: 23333110
[TBL] [Abstract][Full Text] [Related]
12. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole.
Gruchalla RS; Pesenko RD; Do TT; Skiest DJ
J Allergy Clin Immunol; 1998 Mar; 101(3):371-8. PubMed ID: 9525454
[TBL] [Abstract][Full Text] [Related]
13. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.
Morita S; Miwa H; Kondo T
Parkinsonism Relat Disord; 2005 Mar; 11(2):101-3. PubMed ID: 15734668
[TBL] [Abstract][Full Text] [Related]
14. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
[TBL] [Abstract][Full Text] [Related]
15. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility.
Kearns GL; Wheeler JG; Childress SH; Letzig LG
J Pediatr; 1994 Nov; 125(5 Pt 1):805-11. PubMed ID: 7965438
[TBL] [Abstract][Full Text] [Related]
16. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
Wijsman JA; Dekaban GA; Rieder MJ
J Clin Pharmacol; 2005 Mar; 45(3):346-51. PubMed ID: 15703369
[TBL] [Abstract][Full Text] [Related]
17. Cross-sensitivity of skin rashes with antiepileptic drug use.
Hirsch LJ; Arif H; Nahm EA; Buchsbaum R; Resor SR; Bazil CW
Neurology; 2008 Nov; 71(19):1527-34. PubMed ID: 18981374
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
[TBL] [Abstract][Full Text] [Related]
19. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals.
Neuman MG; Malkiewicz IM; Phillips EJ; Rachlis AR; Ong D; Yeung E; Shear NH
Ther Drug Monit; 2002 Dec; 24(6):728-36. PubMed ID: 12451289
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
